BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2008
View Archived Issues
Recent patent literature describes novel treatment options for diabetes
Read More
New compounds for treating HCV infection disclosed in recent patents
Read More
New therapeutic agents for respiratory disorders reported in recent patent literature
Read More
Novel antibiotic shows promising in vitro and in vivo activity against Gram-positive pathogens
Read More
Clinical Data initiates second of two phase III trials of vilazodone for depression
Read More
FDA to review Lev's BLA for Cinryze in hereditary angioedema
Read More
Glycotex completes enrollment in phase IIa study of GLYC-101 for wound healing
Read More
Cytopia presents an update on phase II, phase I and preclinical development of CYT-997
Read More
Oncolys and Tacere sign alliance and license agreement for Asia for HCV drug
Read More
Calando submits IND to FDA to initiate phase I clinical trial of CALAA-01 in cancer
Read More
Preclinical results of TRPV1 antagonist GRC-6211 reported
Read More
GSK's novel NOS-2 inhibitor SB-823387 shows analgesic efficacy in experimental dental pain
Read More
Preclinical profile of cis-ACCP, a novel MMP inhibitor with antimetastatic properties
Read More
FDA recommends approval of Amgen's BLA for romiplostim in immune thrombocytopenic purpura
Read More
Millennium announces publication of clinical results of phase I/II Velcade trial in multiple myeloma
Read More
Dosing initiated in obesity trial with oxyntomodulin analogue TKS-1225
Read More
Genentech to initiate three phase II clinical trials of GDC-0449 in 2008
Read More
Arana begins phase II trial for lead anti-TNF drug candidate
Read More
PregLem commences SAPHIR study for steroid sulfatase inhibitor PGL-2001
Read More
Raven initiates phase II RAV-12 trial in metastatic pancreatic cancer
Read More
Cardiome announces positive interim phase IIb results for oral vernakalant
Read More
Positive efficacy data from EndoTAG-1 phase II clinical trial in pancreatic cancer
Read More
